financetom
Business
financetom
/
Business
/
Bandhan Bank Q2 profit down 5% at Rs 920 cr
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bandhan Bank Q2 profit down 5% at Rs 920 cr
Nov 2, 2020 6:16 AM

Bandhan Bank on Monday reported 5.3 percent decline in net profit at Rs 920 crore for September quarter of the current fiscal year. The bank clocked a net profit of Rs 971.80 crore in the same period of 2019-20.

Total income grew 22 percent to Rs 2,304.90 crore in July-September 2020-21 as against Rs 1,889.30 crore in the year-ago period, Bandhan Bank said in a regulatory filing. Net interest income of the Kolkata-headquartered lender jumped 25.8 percent to Rs 1,923.1 crore during the quarter while the non-interest income grew 6.1 percent to Rs 381.8 crore.

Bandhan Bank said it has reported the highest ever quarterly profit before tax at Rs 1,233 crore during the period under review. Net Interest Margin (annualised) in the quarter fell to 8 percent against 8.2 percent in year-ago period. During the quarter, the bank took accelerated additional provision on standard advances amounting to Rs 300 crore. With this provision and the additional standard assets provision that bank is carrying in micro banking portfolio, the total additional provision in books stands at Rs 2,096 crore, it said.

The bank’s gross non-performing assets fell to 1.2 percent (Rs 874 crore) of gross advances as of September 30, 2020 as against 1.8 percent (Rs 1,064.20 crore) by the year-ago same period. Net NPAs too improved to 0.4 percent (Rs 262.50 crore) from 0.6 percent (Rs 336.90 crore).

”As the moratorium ended on 31st August 2020 coupled with robust rural performance, we have seen an all-round improvement in collection, disbursement and deposits. On deposits front, we have witnessed the best ever quarter whereas on the disbursement front, we are close to pre-COVID-19 level.”

Collections have seen a steady improvement month-on-month and is expected to reach near normal in the next 90 days. We now look forward to accelerate the business in H2FY 21,” Managing Director and CEO Chandra Shekhar Ghosh said. Total Advances grew 19.4 percent to Rs 76,614.6 crore as on September 30, 2020. Total deposits increased 34.4 percent to Rs 66,127.7 crore.

Bandhan Bank stock was trading at Rs 305.50 on BSE, up 5.62 percent from the previous close.

First Published:Nov 2, 2020 3:16 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Labcorp Holdings Launches FDA-Cleared Blood Test Lumipulse to Help Diagnose Alzheimer's Disease
Labcorp Holdings Launches FDA-Cleared Blood Test Lumipulse to Help Diagnose Alzheimer's Disease
Aug 18, 2025
07:39 AM EDT, 08/18/2025 (MT Newswires) -- Labcorp Holdings ( LH ) said Monday that Lumipulse, the first blood test cleared by the US Food and Drug Administration to help diagnose Alzheimer's disease, is now available nationwide. The test offers results that are comparable to existing methods, but is less invasive and more affordable and accessible, the company said. Lumipulse...
Trident Digital Tech Acquires 30% Stake in Tongxin for $3 Million
Trident Digital Tech Acquires 30% Stake in Tongxin for $3 Million
Aug 18, 2025
07:39 AM EDT, 08/18/2025 (MT Newswires) -- Trident Digital Tech ( TDTH ) said Monday that it has agreed to acquire a 30% equity stake in Tongxin Innovation for approximately $3 million. Tongxin Innovation operates the ToMe Web 3.0 e-commerce platform on Telegram. The company said the deal, which values Tongxin at approximately $10 million, will be completed by issuing...
International Petroleum Released Results of Latest Normal Course Issuer Bid
International Petroleum Released Results of Latest Normal Course Issuer Bid
Aug 18, 2025
07:47 AM EDT, 08/18/2025 (MT Newswires) -- International Petroleum ( IPCFF ) earlier on Monday announced that it repurchased a total of 144,952 common shares during the period of August 11 to 15, 2025 under its normal course issuer bid, share repurchase program (NCIB). During the period, IPC repurchased a total of 88,052 IPC common shares on Nasdaq Stockholm. During...
FibroGen Says China Unit Sale to AstraZeneca Receives Regulatory Approval
FibroGen Says China Unit Sale to AstraZeneca Receives Regulatory Approval
Aug 18, 2025
07:44 AM EDT, 08/18/2025 (MT Newswires) -- FibroGen ( FGEN ) said Monday the China State Administration for Market Regulation has approved the sale of its subsidiary in China to AstraZeneca ( AZN ) unit AstraZeneca Treasury. FibroGen ( FGEN ) said the transaction remains on track to close in Q3, pending other contractual conditions and deliverables. FibroGen ( FGEN...
Copyright 2023-2026 - www.financetom.com All Rights Reserved